# Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis

> **NCT06933238** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 70 (estimated)

## Conditions studied

- Sepsis Abdominal
- Gastrointestinal Dysfunction
- Traditional Chinese Medicine

## Interventions

- **DRUG:** Fuzheng Tongfu Jiedu prescription (FZTFJD)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06933238
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-25
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06933238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06933238, "Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06933238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*